GSK BLISSc-ILD 218224 Patient
50+
Downloads
Everyone
info
About this app
This app has been created exclusively for participants in the medical study for GSK BLISSc-ILD. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (SSc-ILD).
A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (SSc-ILD).
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Location, Personal info and 3 others
Data is encrypted in transit
Data can’t be deleted
What’s new
Bug fixes and performance improvements.
App support
About the developer
Medable Inc.
tim@medable.com
525 University Ave Ste A70
Palo Alto, CA 94301
United States
+1 650-231-5478
